Literature DB >> 28676009

Aging Eye Microbiota in Dry Eye Syndrome in Patients Treated with Enterococcus faecium and Saccharomyces boulardii.

Giuseppe Chisari1, Eleonora M Chisari2, Antonio M Borzi3, Clara G Chisari4.   

Abstract

BACKGROUND: Aging and oxidative stress seem to play a key role in the onset and progression of ocular surface diseases. Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface in which symptoms may interfere with the ability to work and carry out daily functions.
METHODS: This clinical trial was a pilot study to evaluate the effects of supplementation with mixture (Saccharomyces boulardii MUCL 53837 and Enterococcus faecium LMG S-28935) on the tear film. Following the run-in period subjects were randomized in two groups: group A (n.30 subjects) and group B (n.30 subjects). Group A (control) treated only with substitute tear and group B treated with substitute tear + mixture (probiotic).
RESULTS: The data obtained in the two study groups A and B were, respectively the following: Schirmer I: 9.2±0.2 vs. 12.8±0.4 (p< 0.001); Schirmer II: 3.6±0.1 vs. 4.6±0.2 (p<0.001); BUT 3.8±0.3 vs. 6.2±0.2 (p<0.001). Culture test showed initial bacterial growth in group "A" (placebo) 27 out of 60 samples tested, corresponding to 45.0% and "B" after treatment (probiotic) was found positive culture whit growth of bacteria in 18 tests equal to 30.0%. The total numbers of isolations of aerobic and anaerobic bacteria found group A and B after treatment. A reduction of 23 to 16 strains of aerobic and anaerobic isolates from 13 to 7 has been found.
CONCLUSION: The administration of probiotics strains was effective in reducing DES. In light of these results, we have identified our probiotic (Saccharomyces boulardii MUCL 53837 and Enterococcus faecium LMG S-28935) activity integration with the action of tear substitutes, along with standardization of clinical parameters of the tear film and microbiological activity in restoring of the microbiota ocular surface subject with DES. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Dry Eye Syndrome (DES); Enterococcus faecium LMGS-zzm32199028935; MUCL 53837; Saccharomyces boulardii; ocular microbiota; symbiotic; tear film.

Mesh:

Substances:

Year:  2017        PMID: 28676009     DOI: 10.2174/1574884712666170704145046

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  5 in total

Review 1.  The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome.

Authors:  Claudia M Trujillo-Vargas; Laura Schaefer; Jehan Alam; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2019-10-20       Impact factor: 5.033

2.  The profile of gut microbiota and central carbon-related metabolites in primary angle-closure glaucoma patients.

Authors:  Haijun Gong; Rui Zeng; Qiguan Li; Yao Liu; Chengguo Zuo; Jiawei Ren; Ling Zhao; Mingkai Lin
Journal:  Int Ophthalmol       Date:  2022-02-11       Impact factor: 2.031

Review 3.  The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?

Authors:  Azadeh Tavakoli; Judith Louise Flanagan
Journal:  Antibiotics (Basel)       Date:  2019-06-30

Review 4.  Can Gut Microbiota Affect Dry Eye Syndrome?

Authors:  Jayoon Moon; Chang Ho Yoon; Se Hyun Choi; Mee Kum Kim
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

5.  Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report.

Authors:  Laura Maria Chisari; Grasso Antonino; Giuseppe Chisari; Antonio Maria Borzì; Clara Grazia Chisari
Journal:  Ann Med Surg (Lond)       Date:  2020-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.